Home> Industry Information> Top 10 China Freeze-dried Human Rabies Vaccine Manufacturers

Top 10 China Freeze-dried Human Rabies Vaccine Manufacturers

June 08, 2024

The Freeze-dried Human Rabies Vaccine market is expected to witness significant growth due to increasing awareness about Rabies Prevention, rising incidence of rabies cases, and advancements in vaccine technology. Key players are focusing on developing cost-effective and efficient freeze-dried vaccines to meet the growing demand.

Changchun Institute of Biological Products Co., Ltd.

Establishment time : 1941

website : http://www.cibp.cnbio.cn/

Main Product : Vaccines, biological products

Company Profile

Changchun Institute of Biological Products Co., Ltd. is a renowned company that specializes in the research, development, and production of vaccines and biological products. With a history dating back to 1941, the company has grown to become a key player in the industry, serving both domestic and international markets. Known for its high-quality products and advanced technologies, the company continues to be a leader in the field, setting the standard for excellence in biological products.

Chengdu Institute of Biological Products Co., Ltd.

Establishment time : 1969

website : http://www.cibp.com.cn/

Main Product : Biological products, vaccines, blood products

Company Profile

Chengdu Institute of Biological Products Co., Ltd. is a renowned biopharmaceutical company with a history dating back to 1969. Specializing in the production of vaccines, blood products, and other biological products, the company has established itself as a key player in the global healthcare industry. With a large workforce of over 2000 employees, the company serves markets in China, Asia, Africa, and Latin America. Known for its high-quality products and strong international presence, Chengdu Institute of Biological Products Co., Ltd. continues to be a leading force in the field of biopharmaceuticals.

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.

Establishment time : 1998

website : www.tianyuanpharm.com

Main Product : Recombinant human insulin, insulin analogs, and other pharmaceutical products

Company Profile

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a leading pharmaceutical company specializing in the production of insulin and other biopharmaceutical products. With a history dating back to 1998, the company has grown to become a key player in the global pharmaceutical market, serving customers in China and around the world. Their commitment to quality and innovation has helped them stay competitive in the rapidly evolving industry.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Wuhan Institute of Biological Products Co., Ltd.

Establishment time : Wuhan Institute of Biological Products Co., Ltd. was established in 1967.

website :

Main Product : With a large company size, Wuhan Institute of Biological Products Co., Ltd. has a strong presence in the market.

Company Profile

Wuhan Institute of Biological Products Co., Ltd. has a reputation for innovation and excellence in the biopharmaceutical sector.

Sinovac Biotech Co., Ltd.

Establishment time : Sinovac Biotech Co., Ltd. is a leading biopharmaceutical company based in China.

website :

Main Product : Sinovac is known for its high-quality vaccines that have been widely used in the prevention of various infectious diseases.

Company Profile

Sinovac is committed to improving global health and is dedicated to providing safe and effective vaccines to people of all ages.

Shenzhen Kangtai Biological Products Co., Ltd.

Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992.

website :

Main Product : With a large company size, Kangtai is a leading manufacturer in the field of biological products.

Company Profile

For more information, visit the company's website at www.kangtai-bio.com.

Beijing Tiantan Biological Products Co., Ltd.

Establishment time : Beijing Tiantan Biological Products Co., Ltd. was founded in 1992.

website :

Main Product : With a large company size, Tiantan Bio is a major player in the industry.

Company Profile

For more information, visit their website at http://www.tiantanbio.com.

The above is the Top 10 China Freeze-dried Human Rabies Vaccine Manufacturers we have listed for you. You can submit the following form to obtain more industry information we provide for you.

You can visit our website or contact us, and we will provide the latest consultation and solutions

Share to:

Send Inquiry

Home> Industry Information> Top 10 China Freeze-dried Human Rabies Vaccine Manufacturers
We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send